title: A potential surrogate marker of efficacy for a therapeutic melanoma vaccine.
authors.affiliation: Ribi ImmunoChem Research, Inc., Hamilton, Montana 59840.
authors.forename: G T
authors.initials: GT
authors.lastname: Elliott
authors.forename: J
authors.initials: J
authors.lastname: Perez
authors.forename: R A
authors.initials: RA
authors.lastname: McLeod
authors.forename: K B
authors.initials: KB
authors.lastname: Von Eschen
mesh_terms: D015703:Antigens, CD / Q000276:immunology; D014408:Biomarkers, Tumor; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods; D016131:Lymphocyte Subsets / Q000276:immunology; D008545:Melanoma / Q000175:diagnosis* / Q000628:therapy; D016019:Survival Analysis
chemical_list: D015703:Antigens, CD; D014408:Biomarkers, Tumor